Published in Appl Environ Microbiol on November 26, 2012
DNA assembly techniques for next-generation combinatorial biosynthesis of natural products. J Ind Microbiol Biotechnol (2013) 0.94
Recent advances in DNA assembly technologies. FEMS Yeast Res (2015) 0.86
Directed evolution of a cellobiose utilization pathway in Saccharomyces cerevisiae by simultaneously engineering multiple proteins. Microb Cell Fact (2013) 0.86
Investigating xylose metabolism in recombinant Saccharomyces cerevisiae via 13C metabolic flux analysis. Microb Cell Fact (2013) 0.86
Engineering biological systems using automated biofoundries. Metab Eng (2017) 0.85
Construction of a quadruple auxotrophic mutant of an industrial polyploid saccharomyces cerevisiae strain by using RNA-guided Cas9 nuclease. Appl Environ Microbiol (2014) 0.85
Metabolic engineering of yeasts by heterologous enzyme production for degradation of cellulose and hemicellulose from biomass: a perspective. Front Microbiol (2014) 0.82
Investigating host dependence of xylose utilization in recombinant Saccharomyces cerevisiae strains using RNA-seq analysis. Biotechnol Biofuels (2013) 0.81
Miniaturized plate readers for low-cost, high-throughput phenotypic screening. J Lab Autom (2014) 0.78
High-throughput evaluation of synthetic metabolic pathways. Technology (Singap World Sci) (2015) 0.77
Combinatorial Screening for Transgenic Yeasts with High Cellulase Activities in Combination with a Tunable Expression System. PLoS One (2015) 0.77
Metabolic engineering of Saccharomyces cerevisiae to produce 1-hexadecanol from xylose. Microb Cell Fact (2016) 0.76
Irradiation of Yarrowia lipolytica NRRL YB-567 creating novel strains with enhanced ammonia and oil production on protein and carbohydrate substrates. Appl Microbiol Biotechnol (2015) 0.75
Directed evolution of a fungal β-glucosidase in Saccharomyces cerevisiae. Biotechnol Biofuels (2016) 0.75
Heterologous xylose isomerase pathway and evolutionary engineering improve xylose utilization in Saccharomyces cerevisiae. Front Microbiol (2015) 0.75
Engineered yeast with a CO2-fixation pathway to improve the bio-ethanol production from xylose-mixed sugars. Sci Rep (2017) 0.75
Systematic Optimization of Protein Secretory Pathways in Saccharomyces cerevisiae to Increase Expression of Hepatitis B Small Antigen. Front Microbiol (2017) 0.75
Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods (2009) 22.47
Harnessing homologous recombination in vitro to generate recombinant DNA via SLIC. Nat Methods (2007) 7.56
Automated design of synthetic ribosome binding sites to control protein expression. Nat Biotechnol (2009) 5.86
Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science (2010) 4.96
Cellulosic biofuels. Annu Rev Plant Biol (2009) 4.00
DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways. Nucleic Acids Res (2008) 3.66
Anaerobic xylose fermentation by recombinant Saccharomyces cerevisiae carrying XYL1, XYL2, and XKS1 in mineral medium chemostat cultures. Appl Environ Microbiol (2000) 2.65
Metabolic engineering of a xylose-isomerase-expressing Saccharomyces cerevisiae strain for rapid anaerobic xylose fermentation. FEMS Yeast Res (2005) 2.39
Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae. Nat Chem Biol (2008) 2.19
High-level functional expression of a fungal xylose isomerase: the key to efficient ethanolic fermentation of xylose by Saccharomyces cerevisiae? FEMS Yeast Res (2003) 2.17
Combining metabolic and protein engineering of a terpenoid biosynthetic pathway for overproduction and selectivity control. Proc Natl Acad Sci U S A (2010) 1.65
Stabilized gene duplication enables long-term selection-free heterologous pathway expression. Nat Biotechnol (2009) 1.65
Engineering of promoter replacement cassettes for fine-tuning of gene expression in Saccharomyces cerevisiae. Appl Environ Microbiol (2006) 1.53
Optimal growth and ethanol production from xylose by recombinant Saccharomyces cerevisiae require moderate D-xylulokinase activity. Appl Environ Microbiol (2003) 1.52
The expression of a Pichia stipitis xylose reductase mutant with higher K(M) for NADPH increases ethanol production from xylose in recombinant Saccharomyces cerevisiae. Biotechnol Bioeng (2006) 1.48
Xylose reductase from Pichia stipitis with altered coenzyme preference improves ethanolic xylose fermentation by recombinant Saccharomyces cerevisiae. Biotechnol Biofuels (2009) 1.37
Bioethanol production performance of five recombinant strains of laboratory and industrial xylose-fermenting Saccharomyces cerevisiae. Bioresour Technol (2009) 1.22
Single-step linker-based combinatorial assembly of promoter and gene cassettes for pathway engineering. Biotechnol Lett (2010) 1.18
Shuffling of promoters for multiple genes to optimize xylose fermentation in an engineered Saccharomyces cerevisiae strain. Appl Environ Microbiol (2007) 1.17
Expression of protein engineered NADP+-dependent xylitol dehydrogenase increases ethanol production from xylose in recombinant Saccharomyces cerevisiae. Appl Microbiol Biotechnol (2008) 1.16
High activity of xylose reductase and xylitol dehydrogenase improves xylose fermentation by recombinant Saccharomyces cerevisiae. Appl Microbiol Biotechnol (2006) 1.15
Changing flux of xylose metabolites by altering expression of xylose reductase and xylitol dehydrogenase in recombinant Saccharomyces cerevisiae. Appl Biochem Biotechnol (2003) 1.12
Directed evolution of xylose isomerase for improved xylose catabolism and fermentation in the yeast Saccharomyces cerevisiae. Appl Environ Microbiol (2012) 1.12
Comparing the xylose reductase/xylitol dehydrogenase and xylose isomerase pathways in arabinose and xylose fermenting Saccharomyces cerevisiae strains. Biotechnol Biofuels (2008) 1.06
Bioethanol production from xylose by recombinant Saccharomyces cerevisiae expressing xylose reductase, NADP(+)-dependent xylitol dehydrogenase, and xylulokinase. J Biosci Bioeng (2008) 1.03
Cloning and characterization of a panel of constitutive promoters for applications in pathway engineering in Saccharomyces cerevisiae. Biotechnol Bioeng (2012) 1.02
Minimization of glycerol synthesis in industrial ethanol yeast without influencing its fermentation performance. Metab Eng (2010) 0.89
Establishment of L-arabinose fermentation in glucose/xylose co-fermenting recombinant Saccharomyces cerevisiae 424A(LNH-ST) by genetic engineering. Appl Microbiol Biotechnol (2010) 0.89
Xylose isomerase improves growth and ethanol production rates from biomass sugars for both Saccharomyces pastorianus and Saccharomyces cerevisiae. Biotechnol Prog (2012) 0.78
Comprehensive human genome amplification using multiple displacement amplification. Proc Natl Acad Sci U S A (2002) 13.58
Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry (2007) 6.59
Unbiased whole-genome amplification directly from clinical samples. Genome Res (2003) 6.29
DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways. Nucleic Acids Res (2008) 3.66
Just what the doctor ordered. Review of the evidence of the impact of computerized physician order entry system on medication errors. Health Serv Res (2008) 2.05
Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease. Mol Biosyst (2012) 2.01
Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology (2010) 1.96
Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology (2008) 1.79
A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms. Am J Surg Pathol (2012) 1.73
Genome-wide association analyses in Han Chinese identify two new susceptibility loci for amyotrophic lateral sclerosis. Nat Genet (2013) 1.57
Yeast surface display of trifunctional minicellulosomes for simultaneous saccharification and fermentation of cellulose to ethanol. Appl Environ Microbiol (2009) 1.55
New insight into the mechanism of methyl transfer during the biosynthesis of fosfomycin. Chem Commun (Camb) (2006) 1.53
Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-kappaB and c-Jun NH2-terminal kinase pathways. Diabetes (2008) 1.52
Heterologous production of fosfomycin and identification of the minimal biosynthetic gene cluster. Chem Biol (2006) 1.47
In vitro fabrication of a tissue engineered human cardiovascular patch for future use in cardiovascular surgery. Ann Thorac Surg (2006) 1.47
Adsorption of ionizable organic contaminants on multi-walled carbon nanotubes with different oxygen contents. J Hazard Mater (2010) 1.45
Cloning, expression, and biochemical characterization of Streptomyces rubellomurinus genes required for biosynthesis of antimalarial compound FR900098. Chem Biol (2008) 1.41
Customized optimization of metabolic pathways by combinatorial transcriptional engineering. Nucleic Acids Res (2012) 1.41
In vitro reconstitution and crystal structure of p-aminobenzoate N-oxygenase (AurF) involved in aureothin biosynthesis. Proc Natl Acad Sci U S A (2008) 1.39
Ibrutinib treatment ameliorates murine chronic graft-versus-host disease. J Clin Invest (2014) 1.38
Recent developments in pyridine nucleotide regeneration. Curr Opin Biotechnol (2003) 1.36
A highly sensitive selection method for directed evolution of homing endonucleases. Nucleic Acids Res (2005) 1.34
A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol (2009) 1.28
Transcription activator-like effector nucleases (TALENs): a highly efficient and versatile tool for genome editing. Biotechnol Bioeng (2013) 1.28
Improving cellular malonyl-CoA level in Escherichia coli via metabolic engineering. Metab Eng (2009) 1.26
Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China. Pharmacogenomics (2008) 1.26
BAG1 plays a critical role in regulating recovery from both manic-like and depression-like behavioral impairments. Proc Natl Acad Sci U S A (2008) 1.25
Thermochromic VO2 thin films: solution-based processing, improved optical properties, and lowered phase transformation temperature. Langmuir (2010) 1.23
Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol Rep (2006) 1.22
Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs. Biotechnol Bioeng (2013) 1.19
Discovery and characterization of novel d-xylose-specific transporters from Neurospora crassa and Pichia stipitis. Mol Biosyst (2010) 1.19
Rapid characterization and engineering of natural product biosynthetic pathways via DNA assembler. Mol Biosyst (2011) 1.18
Biosynthesis of 2-hydroxyethylphosphonate, an unexpected intermediate common to multiple phosphonate biosynthetic pathways. J Biol Chem (2008) 1.17
Directed evolution of enzymes and biosynthetic pathways. Curr Opin Microbiol (2006) 1.16
Differential DNA methylation in discrete developmental stages of the parasitic nematode Trichinella spiralis. Genome Biol (2012) 1.16
Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test. Neuropharmacology (2007) 1.16
Reconstitution and characterization of aminopyrrolnitrin oxygenase, a Rieske N-oxygenase that catalyzes unusual arylamine oxidation. J Biol Chem (2005) 1.15
A new class of arylamine oxygenases: evidence that p-aminobenzoate N-oxygenase (AurF) is a di-iron enzyme and further mechanistic studies. Chembiochem (2006) 1.15
Relaxing the nicotinamide cofactor specificity of phosphite dehydrogenase by rational design. Biochemistry (2003) 1.13
High accuracy genotyping directly from genomic DNA using a rolling circle amplification based assay. BMC Genomics (2003) 1.13
Engineering microbial factories for synthesis of value-added products. J Ind Microbiol Biotechnol (2011) 1.13
Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system. Ann N Y Acad Sci (2003) 1.11
Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy. FASEB J (2005) 1.11
The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers. J Neurosci (2005) 1.10
Activation and characterization of a cryptic polycyclic tetramate macrolactam biosynthetic gene cluster. Nat Commun (2013) 1.09
Directed evolution of specific receptor-ligand pairs for use in the creation of gene switches. Proc Natl Acad Sci U S A (2005) 1.08
Protein engineering in designing tailored enzymes and microorganisms for biofuels production. Curr Opin Biotechnol (2009) 1.08
Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology (2008) 1.07
Directed evolution of a thermostable phosphite dehydrogenase for NAD(P)H regeneration. Appl Environ Microbiol (2005) 1.06
MAPK phosphatase-3 promotes hepatic gluconeogenesis through dephosphorylation of forkhead box O1 in mice. J Clin Invest (2010) 1.05
Biosynthesis of phloroglucinol. J Am Chem Soc (2005) 1.03
Refactoring the silent spectinabilin gene cluster using a plug-and-play scaffold. ACS Synth Biol (2013) 1.02
Heterologous expression, purification, and characterization of a highly active xylose reductase from Neurospora crassa. Appl Environ Microbiol (2005) 1.02
Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells. Pancreas (2007) 1.02
Cloning and characterization of a panel of constitutive promoters for applications in pathway engineering in Saccharomyces cerevisiae. Biotechnol Bioeng (2012) 1.02
Distinct structural elements dictate the specificity of the type III pentaketide synthase from Neurospora crassa. Chem Biol (2008) 1.01
Mutagenic inverted repeat assisted genome engineering (MIRAGE). Nucleic Acids Res (2008) 1.01
Evaluation of breast lesions by contrast enhanced ultrasound: qualitative and quantitative analysis. Eur J Radiol (2011) 1.01
Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage. Int J Neuropsychopharmacol (2009) 1.00
Flow injection analysis of chemical oxygen demand (COD) by using a boron-doped diamond (BDD) electrode. Environ Sci Technol (2009) 0.99
Directed evolution of human estrogen receptor variants with significantly enhanced androgen specificity and affinity. J Biol Chem (2004) 0.99
Directed evolution: an evolving and enabling synthetic biology tool. Curr Opin Chem Biol (2012) 0.99
A family-based association study of schizophrenia with polymorphisms at three candidate genes. Neurosci Lett (2005) 0.98
Recent advances in targeted genome engineering in mammalian systems. Biotechnol J (2012) 0.97
Enhancement patterns and parameters of breast cancers at contrast-enhanced US: correlation with prognostic factors. Radiology (2012) 0.96
Characterization of heme ligation properties of Rv0203, a secreted heme binding protein involved in Mycobacterium tuberculosis heme uptake. Biochemistry (2012) 0.96
Directed evolution of soluble single-chain human class II MHC molecules. J Mol Biol (2004) 0.96
Efficient regeneration of NADPH using an engineered phosphite dehydrogenase. Biotechnol Bioeng (2007) 0.95
Directed evolution of LuxI for enhanced OHHL production. Biotechnol Bioeng (2008) 0.95
Ultrasmall Sn nanoparticles embedded in nitrogen-doped porous carbon as high-performance anode for lithium-ion batteries. Nano Lett (2013) 0.95
Enhancing electrocatalytic oxygen reduction on MnO(2) with vacancies. Angew Chem Int Ed Engl (2013) 0.95
Engineered biosynthesis of natural products in heterologous hosts. Chem Soc Rev (2015) 0.95
Association study between methylenetetrahydrofolate reductase polymorphisms and unexplained recurrent pregnancy loss: a meta-analysis. Gene (2012) 0.95
Up-regulated HIF-1alpha is involved in the hypoxic tolerance induced by hyperbaric oxygen preconditioning. Brain Res (2008) 0.95
Applying an electric field in a built-in zero valent iron--anaerobic reactor for enhancement of sludge granulation. Water Res (2010) 0.94
Actinoalloteichus nanshanensis sp. nov., isolated from the rhizosphere of a fig tree (Ficus religiosa). Int J Syst Evol Microbiol (2010) 0.94
Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder? Neurobiol Dis (2010) 0.94
FairyTALE: a high-throughput TAL effector synthesis platform. ACS Synth Biol (2013) 0.94
DNA assembly techniques for next-generation combinatorial biosynthesis of natural products. J Ind Microbiol Biotechnol (2013) 0.94
Protection against oxidative stress in diabetic rats: role of angiotensin AT(1) receptor and beta 1-adrenoceptor antagonism. Eur J Pharmacol (2005) 0.94
Three-dimensional imaging of normal skin and nonmelanoma skin cancer with cellular resolution using Gabor domain optical coherence microscopy. J Biomed Opt (2012) 0.94
Further improvement of phosphite dehydrogenase thermostability by saturation mutagenesis. Biotechnol Bioeng (2008) 0.94
Deciphering the late biosynthetic steps of antimalarial compound FR-900098. Chem Biol (2010) 0.93
Rapid identification of CD4+ T-cell epitopes using yeast displaying pathogen-derived peptide library. J Immunol Methods (2008) 0.93
Downregulation of connexin 43 expression by high glucose induces senescence in glomerular mesangial cells. J Am Soc Nephrol (2006) 0.93
Mechanistic studies on the conversion of arylamines into arylnitro compounds by aminopyrrolnitrin oxygenase: identification of intermediates and kinetic studies. Angew Chem Int Ed Engl (2006) 0.92
Probing the oxyferrous and catalytically active ferryl states of Amphitrite ornata dehaloperoxidase by cryoreduction and EPR/ENDOR spectroscopy. Detection of compound I. J Am Chem Soc (2010) 0.92
Integrating plasmonic nanoparticles with TiO₂ photonic crystal for enhancement of visible-light-driven photocatalysis. Environ Sci Technol (2012) 0.92
Overcoming glucose repression in mixed sugar fermentation by co-expressing a cellobiose transporter and a β-glucosidase in Saccharomyces cerevisiae. Mol Biosyst (2010) 0.92
Genome-scale consequences of cofactor balancing in engineered pentose utilization pathways in Saccharomyces cerevisiae. PLoS One (2011) 0.91
Directed evolution as a powerful synthetic biology tool. Methods (2012) 0.91
Biocatalyst development by directed evolution. Bioresour Technol (2012) 0.91
Directed evolution of the nonribosomal peptide synthetase AdmK generates new andrimid derivatives in vivo. Chem Biol (2011) 0.91
The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder. Biol Psychiatry (2010) 0.91
Direct cloning of large genomic sequences. Nat Biotechnol (2012) 0.91
Contrast-enhanced ultrasonography with contrast-tuned imaging technology for the detection of prostate cancer: comparison with conventional ultrasonography. BJU Int (2011) 0.90
Catalpol attenuates the neurotoxicity induced by beta-amyloid(1-42) in cortical neuron-glia cultures. Brain Res (2007) 0.90
Rapid creation of a novel protein function by in vitro coevolution. J Mol Biol (2005) 0.90
Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets. Circulation (2014) 0.90